Press Releases

Sanofi and the Curie Institute, through its Curie-Cancer partnership under the Institut Carnot label, today announce the establishment of a three-year research collaboration to identify new therapeutic targets for the development of treatments for ovarian cancer. ...

The inaugural World Research and Innovation Congress took place at the Steigenberger Grandhotel in Brussels on 5 and 6 June. It was a truly international event attended by senior scientific healthcare delegates from over 50 different countries with the...

Clovis Oncology announced today the pricing of an underwritten public offering of 3333334 shares of its common stock at $72.00 per share before underwriting discounts and commissions. The size of the offering was upsized from...

Cancer vaccine specialist Targovax today announced that it has raised a total of $3.6 million to accelerate development of its RAS mutation-targeted therapeutic cancer vaccine pipeline specifically lead candidate TG01 for pancreatic cancer. The funds...

Ferrer, a privately-held Spanish pharmaceutical company with full vertical integration from R&D to distribution, announces today that it has successfully completed a phase III clinical trial in adult and paediatric patients with impetigo involving Ozenoxacin formulated as a topical...

Biogen Idec Inc. announced today that its 2013 Annual Shareholder Meeting will be webcast live on Wednesday June 12 2013 at 9:00 a.m. ET. To access the live webcast please visit Biogen Idec’s Investors section at www.biogenidec.com. An archived...

Novasep, a leading supplier of manufacturing solutions to the life sciences industry, announces it has strengthened its position in the fine chemicals marketplace with the appointment of Udo Steinhauer as fine chemicals market director within the synthesis business unit...